Cipvildin 50mg Tablet 15

Cipla Ltd.

Strip of 15 Units

MRP ₹148.5

₹74.1

₹9.9/Units

50.1% off
*MRP inclusive of all taxes
Get it By
Change
Choose your location

Use your current location

100% genuine medicines

Safe & secure payments

15 days Easy returns

Prescription required for this medicine

Store Below 30o C

About Cipvildin 50 mg Tablet

Cipvildin 50 mg Tablet is a medicine used to manage type 2 diabetes mellitus. It helps control blood sugar levels and prevent complications like kidney damage and blindness. It works by helping the body produce more insulin after a meal and reducing the amount of excess glucose released into the blood.

This medicine should be taken as prescribed by your doctor, along with a healthy diet and regular exercise. To ensure maximum effectiveness, take Cipvildin 50 mg Tablets at the same time each day. Remember to consult your doctor for the correct dosage based on your condition and blood sugar levels.

It is important to inform your doctor about any existing medical conditions, medications you are taking, and if you are pregnant or breastfeeding. Limit alcohol intake while using this medicine as it can increase the risk of low blood sugar levels.

Last Updated On 23 Dec. 2024 | 10:53AM (IST)

Certified Content

Written by

Aditi Acharya
Aditi Acharya
Medical Content Writer | 5 years

MDS in Pediatric Dentistry

Reviewed by

Dr. Snigdha Sharma
Dr. Snigdha Sharma
Clinical Health & Medical Reviewer | 7 years

MBBS

Check out Editorial Policy

Manufacturer details

Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Country of origin: INDIA

References

  • Vildagliptin. (n.d.). Medline Plus. Retrieved August 26, 2023, from https://pubmed.ncbi.nlm.nih.gov/17100408/
  • Rosenstock, J., & Fitchet, M. (2008). Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes. International Journal of Clinical Practice, 62, 15-23.
  • Cai, L., Cai, Y., Lu, Z. J., Zhang, Y., & Liu, P. (2012). The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta‐analysis of randomized clinical trials. Journal of clinical pharmacy and therapeutics, 37(4), 386-398.
  • Schweizer, A., Dejager, S., Foley, J. E., Shao, Q., & Kothny, W. (2011). Clinical experience with vildagliptin in the management of type 2 diabetes in a patient population≥ 75 years: a pooled analysis from a database of clinical trials. Diabetes, Obesity and Metabolism, 13(1), 55-64.
  • Schweizer, A., Dejager, S., Foley, J. E., & Kothny, W. (2011). Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies. Vascular Health and Risk Management, 49-57.
  • Pi-Sunyer, F. X., Schweizer, A., Mills, D., & Dejager, S. (2007). Efficacy and tolerability of vildagliptin monotherapy in drug-naive patients with type 2 diabetes. Diabetes research and clinical practice, 76(1), 132-138.
Was this product description useful?
41 people find this information helpful

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.

Subscribe

Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.

Registered Office Address

Intellihealth Solutions Private Limited
Office Unit no. 1, 2, 5, & 7, 6th floor Urmi Corporate Park Solaris, Saki Vihar Rd, Opp. L&T Flyover, New Mhada Colony, Budhia Jadhav Wadi, Mumbai, Maharashtra 400072.
CIN: U85320MH2019PTC320566
Telephone:09240250346

Grievance Officer

Name: Chandrasekhar Swaminathan

Download Truemeds

Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
playstoreIcon

Contact Us

Our customer representative team is available 7 days a week from 9 am - 9 pm.


v3.6.7

copyright2025 - Truemeds | All rights reserved

Our Payment Partners

paymentPartnerpaymentPartnerpaymentPartnerpaymentPartnerpaymentPartner
paymentPartnerpaymentPartnerpaymentPartnerpaymentPartner